Product Information
SUCRALFATE 1 GM/10 ML SUSP is a generic product labeled by TruPharma LLC, priced at $0.1371 per ML under NDC 52817084016. Its NADAC has been published 111 times since Aug 21, 2024.
FDA first approved this application on Jan 17, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/10mL
Manufacturer
TruPharma LLCNDC
52817084016
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SUCRALFATEApproval Type
Generic (ANDA)
FDA Application
ANDA213549FDA Approved
1/17/2024
TE Code
AB
On Market Since
4/1/2024
Pharmacological Classes
Price Statistics
The NADAC for SUCRALFATE 1 GM/10 ML SUSP has been published 111 times since Aug 21, 2024, and over the history we have for it it has declined 32.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1371 per ML |
|---|---|
| All-time high | $0.2032 (Sep 11, 2024) |
| All-time low | $0.0751 (Nov 20, 2024) |
| 52-week high | $0.1446 |
| 52-week low | $0.1002 |
| Median price | $0.1236 |
| Average price | $0.1300 |
| Largest weekly change | +63.9% (Dec 18, 2024) |
| Weeks tracked | 111 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
TruPharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sucralfate Oral market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aluminum Complex class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUCRALFATE 1 GM/10 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM/10 ML SUSP, manufactured by TruPharma LLC, is $0.1371 per ML (NDC 52817084016), effective Sep 30, 2026.
How has the price of SUCRALFATE 1 GM/10 ML SUSP changed over time?
Over the history we have for it, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has declined 32.5%. It has been tracked across 111 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM/10 ML SUSP?
Since Aug 21, 2024, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has ranged from a low of $0.0751 (Nov 20, 2024) to a high of $0.2032 (Sep 11, 2024), with a median of $0.1236 per ML.
Are there cheaper alternatives to SUCRALFATE 1 GM/10 ML SUSP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUCRALFATE 1 GM/10 ML SUSP, is $0.1241 per ML — about 9% below SUCRALFATE 1 GM/10 ML SUSP.
Who manufactures SUCRALFATE 1 GM/10 ML SUSP?
SUCRALFATE 1 GM/10 ML SUSP (NDC 52817084016) is labeled by TruPharma LLC, and CMS classifies it as a generic product.